A key role of C5a/C5aR activation for the development of sepsis
Authors:
- 1 August 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 74 (6) , 966-970
Abstract
In recent studies, evidence has been provided for complement activation early during the onset of experimental sepsis. Excessive production of the anaphylatoxin C5a thereby appears to elicit various harmful effects. Blockade of C5a or C5a receptor (C5aR) at the start of experimental sepsis has been demonstrated to greatly improve survival in rodents. There is evidence that C5a, during the onset of sepsis, enhances the production of various proinflammatory mediators in different cell types. Besides its known, other proinflammatory effects, recent work suggested an inhibitory role of C5a for innate-immune functions of phagocytic cells (phagocytosis, reactive oxygen species production, chemotaxis) during experimental sepsis. This review article provides an overview of the important role of C5a/C5aR activation for the onset and development of sepsis.Keywords
This publication has 37 references indexed in Scilit:
- Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of SepsisThe American Journal of Pathology, 2002
- Chronological changes in the complement system in sepsisSurgery Today, 1996
- Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cellsImmunology Letters, 1995
- The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivoInflammation Research, 1991
- Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itselfBlood, 1990
- Complement levels in septic primates treated with anti-C5a antibodiesJournal of Surgical Research, 1989
- Anaphylatoxin Formation in SepsisArchives of Surgery, 1988
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.Journal of Clinical Investigation, 1978
- Generation of C5-Derived Lysosomal Enzyme-Releasing Activity (C5a) by Lysates of Leukocyte LysosomesThe Journal of Immunology, 1974
- Chemotactic and Anaphylatoxic Fragment Cleaved from the Fifth Component of Guinea Pig ComplementScience, 1968